• 1
    The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272: 192631.
  • 2
    Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 60913.
  • 3
    Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effect in controlled trials. JAMA 1995; 273: 40812.
  • 4
    Verhagen AP, de Vet HCW, de Bie RA,Kessels AGH, Boers M, Bouter LM et al. The Delphi List: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 123541.
  • 5
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 6
    Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994; 154: 15763.
  • 7
    Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000; 136: 3815.
  • 8
    Anderson JJ, Felson DT, Meenan RF. Secular changes in published clinical trials of second-line agents in rheumatoid arthritis. Arthritis Rheum 1991; 34: 13049.
  • 9
    Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C. Effectiveness of antidepressants: meta-analysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry 1999; 174: 297300.
  • 10
    Hollis S, Campbell F. What is meant by intention to treat analysis: survey of published randomised controlled trials. BMJ 1999;319: 6705.
  • 11
    Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 1224.
  • 12
    Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R et al. Sponsorship, authorship and accountability. N Engl J Med 2001; 345: 8256.
  • 13
    Moher D, Jones A, Lepage L, the CONSORT group. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 2001; 285: 19925.
  • 14
    Schulz KF. Assessing allocation concealment and blinding in randomized controlled trials: why bother? ACP J Club 2000; 132: A112.